Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells

Published:2022-08-08 Issue:16 Volume:14 Page:6381-6414
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Rysanek David¹,Vasicova Pavla¹,Kolla Jayaprakash Narayana²,Sedlak David²,Andera Ladislav¹³,Bartek Jiri¹⁴,Hodny Zdenek¹

Affiliation:

1. Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic

2. CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic

3. Biocev, Institute of Biotechnology of the Czech Academy of Sciences, Prague, Czech Republic

4. Genome Integrity Unit, Danish Cancer Society Research Center, Copenhagen, Denmark

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference75 articles.

1. Senescence and senotherapeutics: a new field in cancer therapy.;Gorgoulis;Pharmacol Ther,2019

2. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence.;Beauséjour;J Biol Chem,2006

3. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.;Campisi;PLoS Biol,2008

4. A proteomic atlas of senescence-associated secretomes for aging biomarker development.;Schilling;PLoS Biol,2020

5. A senescent cell bystander effect: senescence-induced senescence.;von Zglinicki;Aging Cell,2012

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer: Emerging Modifiable Risk Factors and Therapeutic Strategies in the Management of Advanced Cancer;Life;2024-08-30

2. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30

3. Cellular senescence in metastatic prostate cancer: A therapeutic opportunity or challenge (Review);Molecular Medicine Reports;2024-07-08

4. New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions;International Journal of Molecular Sciences;2024-06-05

5. A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research;Molecular Pharmacology;2024-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3